Aly AK. Editorial Comment: Percutaneous Ablation of Early-Stage Non-Small Cell Lung Cancer Has Reasonable Safety Profile in Patients With Interstitial Lung Disease. AJR Am J Roentgenol 2023 Nov 29. doi: 10.2214/AJR.23.30579.
PMID: 38019475